French Endocrine Society Guidance on endocrine side effects of immunotherapy

The management of cancer patients has changed due to the considerably more frequent use of immune checkpoint inhibitors (ICPIs). However, the use of ICPI has a risk of side effects, particularly endocrine toxicity. Since the indications for ICPI are constantly expanding due to their efficacy, it is...

Descripción completa

Detalles Bibliográficos
Autores principales: Castinetti, F, Albarel, F, Archambeaud, F, Bertherat, J, Bouillet, B, Buffier, P, Briet, C, Cariou, B, Caron, Ph, Chabre, O, Chanson, Ph, Cortet, C, Do Cao, C, Drui, D, Haissaguerre, M, Hescot, S, Illouz, F, Kuhn, E, Lahlou, N, Merlen, E, Raverot, V, Smati, S, Verges, B, Borson-Chazot, F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2018
Materias:
Guidelines and Guidance
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347286/
https://www.ncbi.nlm.nih.gov/pubmed/30400055
http://dx.doi.org/10.1530/ERC-18-0320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347286/
https://www.ncbi.nlm.nih.gov/pubmed/30400055
http://dx.doi.org/10.1530/ERC-18-0320

Ejemplares similares